Although the FDA has not fully authorized the COVID-19 vaccines, it has granted emergency use permission to three of them.
As of June 16, the COVID-19 has killed over 590,000 individuals in the U.S. The FDA has issued an emergency use authorization (EUA) for three COVID-19 vaccines. Pfizer-BioNTech, Moderna, and Johnson & Johnson have been granted authorization for emergency use by the FDA.
Under the Emergency Use Authorization details provided by the FDA, the FDA issues a EUA to allow unapproved medical products to be used in an emergency where there are no adequate or approved alternatives. It further mentioned that the issuance of a EUA is different than full FDA approval (licensure) of a vaccine, in that a vaccine available under a EUA has not been approved.
On May 10, 2021, the FDA also authorized the emergency use of the Pfizer vaccine for children after conducting clinical trials on it since October 2020.
COVID-19 vaccinations have proven to be effective in preventing symptomatic and severe infection of the virus. As a result, getting vaccinated reduces the risk of developing asymptomatic infection and spreading the virus to others.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organization or your national healthcare authority.